Approval · Notice of Compliance 23663 · 2020
PUREGON: Notice of Compliance 23663
Issued May 22, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23663
- Date
- May 22, 2020
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PUREGON | Not yet assigned | — |
Medicinal ingredients
- FOLLITROPIN BETA 100 UNIT per 0.5ML
- FOLLITROPIN BETA 350 UNIT per CART
- FOLLITROPIN BETA 650 UNIT per CART
- FOLLITROPIN BETA 975 UNIT per CART